20% of India's adult population fully vaccinated: Health ministry

The government has also condemned the report by the New York Times that said that the ICMR suppressed data showing the risks of a second wave

Kerala, Coronavirus, Covid-19, vaccine, vaccination
India has so far given almost 770 million vaccine doses
Ruchika Chitravanshi New Delhi
3 min read Last Updated : Sep 17 2021 | 12:21 AM IST
India has fully vaccinated 20 per cent of its adult population for Covid, while 62 per cent have received at least one dose, the health ministry said on Thursday. Amid studies indicating waning antibodies for both Covishield and Covaxin vaccines, the government said that booster dose is not the central theme of scientific and public health discussions. 

“Getting full vaccination is a priority. Antibody levels should not be the measure of immunity,” said Balram Bhargava, director general, Indian Council of Medical Research (ICMR). 

Bhargava said the vaccines can generate cellular or mucosal immunity and not just antibody-related immunity. 

India has so far given almost 770 million vaccine doses. The average vaccination has been the highest in September so far, with more than 7.4 million doses given per day against around 6 million average daily doses administered in August. 

The health ministry also clarified that there is no earmarked quota of vaccines for the private sector and that the 25 per cent allocation for private hospitals is an indicative quantity of vaccines which would be made available to them. 

Health Secretary Rajesh Bhushan said, “If the private sector is unable to procure or utilise the earmarked percentage, whatever is the shortfall will be procured by the government. Whatever is produced in the country must be utilised.” 

The government has also condemned the report by the New York Times that said that the ICMR suppressed data showing the risks of a second wave. The report said, “They pressured scientists to withdraw another study that called the government’s efforts into question, the researchers said, and distanced the agency from a third study that foresaw a second wave.” 

Calling the report provocative and attention-seeking, Bharagava said it had been published at a time when India was doing good and vaccination numbers were excellent. “All issues raised are dead ones which do not merit attention,” he said.

Bhushan said that the government’s focus is on fighting the pandemic. “We cannot afford to be diverted by things that can be addressed at a later date, which are not a priority from a public health point of view.”  Thirty-two districts in India are still reporting a weekly positivity rate between five and ten per cent and 34 districts are reporting more than 10 per cent weekly positivity. The government has advised people to act responsibly while travelling or celebrating the upcoming festivals and ensure double vaccination.

So far 10 states — including Kerala, which is contributing highest to the active caseload of the country — have vaccinated more than 85 per cent of their eligible population with a single dose.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDelta variant of coronavirusVaccinationCoronavirus VaccineVaccine

Next Story